SCHEMBL7651884

SCHEMBL7651884

COC(=O)c1cc(C(C)C(=O)O)ccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 1/20 0.50
AKR1C3 P42330 7/20 0.49
AKR1C2 P52895 7/20 0.49
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 1/20 0.46
PTGS2 P35354 4/20 0.44
PTGS1 P23219 2/20 0.44
CDC42 P60953 1/20 0.44
RAC1 P63000 1/20 0.44
CYP1A2 P05177 1/20 0.44
TSHR P16473 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDGFRB P09619 1/20 0.41
FGFR1 P11362 1/20 0.41
PDGFRA P16234 1/20 0.41
FLT1 P17948 1/20 0.41
FGFR3 P22607 1/20 0.41
KDR P35968 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27811747 0.84 SIRT6 (0.51) SIRT6TDP1MAPTSMN1; SMN2PDGFRB
SCHEMBL2598054 0.81 KMT2A (0.45) AKR1C3AKR1C2MAPTPTGS2PTGS1
SCHEMBL2598053 0.81 KMT2A (0.45) AKR1C3AKR1C2MAPTPTGS2PTGS1
SCHEMBL11095361 0.81 DTYMK (0.52) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL2954624 0.80 AKR1C3 (0.60) AKR1C3AKR1C2TDP1PTGS2PTGS1
SCHEMBL5947600 0.80 AKR1C3 (0.60) AKR1C3AKR1C2TDP1PTGS2PTGS1
SCHEMBL7290814 0.80 SIRT6 (0.49) SIRT6AKR1C3AKR1C2TDP1MAPT
SCHEMBL8803643 0.80 TDP1 (0.49) SIRT6TDP1MAPTSMN1; SMN2PDGFRB
SCHEMBL2597746 0.78 AKR1C3 (0.58) AKR1C3AKR1C2MAPTPTGS2PTGS1
SCHEMBL2597745 0.78 AKR1C3 (0.58) AKR1C3AKR1C2MAPTPTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed